Compressive Myofascial Release of the Vastus Lateralis on Lateral Patellar Tracking in Patellofemoral Pain Syndrome

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 10, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called compressive myofascial release (CMFR) to see if it can help improve knee pain and movement in people with Patellofemoral Pain Syndrome. This condition often results in pain at the front of the knee, especially during activities like running, squatting, or climbing stairs. The trial will involve 26 participants aged 20 to 40 who have been diagnosed with this syndrome and experience specific symptoms, like pain during certain movements and abnormal knee tracking.

Participants will be divided into two groups: one group will receive the CMFR treatment on a muscle called the vastus lateralis, while the other group will get a standard treatment. The treatment will last for four weeks, with sessions happening three times a week. Throughout the trial, researchers will assess changes in knee movement and how much pain participants feel before and after the treatment. This study aims to find out if CMFR can help correct knee tracking issues and reduce pain for those suffering from Patellofemoral Pain Syndrome.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age group between 20 to 40 years
• • Male and female gender
• • Diagnosed cases of Patellofemoral syndrome
• • Participants with positive J sign and Clarke's test
• • Pain provoked during knee loading physical activity, such as jumping, running, squatting, or going up or down stairs in last 3 months
• • Presence of excessive lateral patellar tracking on axial view radiographs
• Exclusion Criteria:
• • History of knee surgery in the past year.
• • Any contraindications to myofascial release therapy, such as active infections, open wounds.
• • Presence of hip pathology or other knee conditions such as ligament tears, meniscal injuries, Osgood-Schlatter or Sinding-Larsen-Johanssen syndrome or jumpers knee
• • Participants with a history of trauma or repetitive episodes of patellar subluxation or dislocation
• • Use of intra-articular corticosteroid injections
• • Presence of auto-immune disorder (spondylolisthesis, spondylitis, Rheumatoid arthritis etc.) other than knee OA or systemic conditions such as severe cardiovascular disease